Electra Therapeutics INC(ETRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ETRA Electra Therapeutics INC

盘前交易 10-08 06:48:13 EDT

9.16

-0.66

-6.72%

最高9.73	最低8.92	成交量40.73万
今开9.72	昨收9.82	日振幅8.25%
总市值5.60亿	流通市值1.98亿	总股本6,110万
成交额374.55万	换手率1.88%	流通股本2,167万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ETRA","market":"US","secType":"STK","nameCN":"Electra Therapeutics INC","latestPrice":9.16,"timestamp":1791403200000,"preClose":9.82,"halted":0,"volume":407261,"delay":0,"changeRate":-0.06720977596741345,"floatShares":21666667,"shares":61100300,"eps":-2163.6592,"marketStatus":"盘前交易","change":-0.66,"latestTime":"10-08 06:48:13 EDT","open":9.72,"high":9.73,"low":8.92,"amount":3745470.271052,"amplitude":0.082485,"askPrice":13.97,"askSize":100,"bidPrice":3.69,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2163.6592,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791466200000},"marketStatusCode":1,"adr":0,"listingDate":1789704000000,"exchange":"NASDAQ","adjPreClose":9.16,"postHourTrading":{"tag":"盘后","latestPrice":9.16,"preClose":9.16,"latestTime":"19:30 EDT","volume":2688,"amount":24622.1,"timestamp":1791415802219,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5837608637663141},"requestUrl":"/m/hq/s/ETRA","defaultTab":"news","newsList":[{"id":"2668094871","title":"免疫学药物研发公司Electra(ETRA.US)IPO定价15美元募资3.5亿 今晚登陆纳斯达克","url":"https://stock-news.laohu8.com/highlight/detail?id=2668094871","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668094871?lang=zh_cn&edition=full","pubTime":"2026-09-18 14:56","pubTimestamp":1789714618,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段免疫学药物开发公司Electra Therapeutics Inc.通过扩大规模的美国首次公开募股募集了3.5亿美元，发行价定在推介区间的中点。Electra的主要候选药物旨在治疗继发性噬血细胞性淋巴组织细胞增生症，这是一种严重的免疫系统过度反应。本次上市恰逢药企IPO行情火热。根据文件，Electra于10月完成了约1.827亿美元的C轮融资，由法国制药商赛诺菲旗下部门、OrbiMed和Redmile领投;截至今年6月30日，公司持有9770万美元现金及现金等价物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667612838","title":"生物科技公司Electra Therapeutics(ETRA.US)IPO定价14-16美元/股 拟筹资3.25亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667612838","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667612838?lang=zh_cn&edition=full","pubTime":"2026-09-15 15:18","pubTimestamp":1789456715,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于开发靶向SIRP抗体、用于免疫疾病和癌症治疗的II/III期的生物科技公司Electra Therapeutics周一公布了首次公开募股的发行条款。Electra Therapeutics正在开发一类精准药物，靶向特定免疫细胞群体上表达的信号调节蛋白。Electra Therapeutics欲借今年生物科技板块IPO强劲表现的东风，为其处于临床阶段的免疫介导疾病和癌症药物管线筹集资金。汇编数据显示，今年美国生物科技与制药公司的IPO累计募资额已达68亿美元，平均加权回报率接近70%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGNG","ETRA","IBBJ","159837","XBI","UDN","LNGR","BK4585","BK4007","BK4581","GDOC","IEIH","MEDX","LENZ","IPOS","BK4139","BK4588","SYNB","UUP","HBImain","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://electra-therapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1858},{"period":"1month","weight":-0.3893},{"period":"ytd","weight":-0.3893}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0091},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.1439},{"period":"1year","weight":0.1616},{"period":"ytd","weight":0.1398}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Electra Therapeutics, Inc.成立于2018年，是一家处于临床后期阶段的生物制药公司，致力于开发用于治疗免疫介导疾病和癌症的新型精准药物。该公司的研发策略靶向信号调节蛋白（SIRP），这是一类细胞表面受体，其表达仅限于特定的免疫细胞群，并在激活后表达上调。SIRP能够选择性地清除致病细胞，同时保留正常的免疫功能。该公司的主要候选产品是ipsoprubart，一种新型泛SIRP单克隆抗体，旨在选择性地清除病理性髓系细胞和T细胞。此外，该公司还在推进ELA822的研发，ELA822是一种新型SIRPg特异性单克隆抗体，旨在选择性地清除活化的T细胞，具有治疗慢性T细胞介导的免疫和炎症性疾病的潜在应用价值。","exchange":"NASDAQ","name":"Electra Therapeutics INC","nameEN":"ELECTRA THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Electra Therapeutics INC(ETRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Electra Therapeutics INC(ETRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Electra Therapeutics INC,ETRA,Electra Therapeutics INC股票,Electra Therapeutics INC股票老虎,Electra Therapeutics INC股票老虎国际,Electra Therapeutics INC行情,Electra Therapeutics INC股票行情,Electra Therapeutics INC股价,Electra Therapeutics INC股市,Electra Therapeutics INC股票价格,Electra Therapeutics INC股票交易,Electra Therapeutics INC股票购买,Electra Therapeutics INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Electra Therapeutics INC(ETRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Electra Therapeutics INC(ETRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}